Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Smart Biosensors Market

ID: MRFR/HC/17980-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

US Smart Biosensors Market Research Report By Product Type (Wearable Biosensors, Non-wearable Biosensors), By Technology (Electrochemical Biosensors, Others), By Application (Drug Discovery, Others) and By End User (Point-Of-Care, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Smart Biosensors Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product Type (USD Billion)
  49.     4.1.1 Wearable Biosensors
  50.     4.1.2 Non-wearable Biosensors
  51.   4.2 Healthcare, BY Technology (USD Billion)
  52.     4.2.1 Electrochemical Biosensors
  53.     4.2.2 Piezoelectric Biosensors
  54.     4.2.3 Optical Biosensors
  55.     4.2.4 Thermal Biosensors
  56.     4.2.5 Nanomechanical Biosensors
  57.     4.2.6 Others
  58.   4.3 Healthcare, BY Application (USD Billion)
  59.     4.3.1 Blood Glucose Testing
  60.     4.3.2 Cholesterol Testing
  61.     4.3.3 Blood Gas Analysis
  62.     4.3.4 Pregnancy Testing
  63.     4.3.5 Drug Discovery
  64.     4.3.6 Infectious Disease Testing
  65.     4.3.7 Others
  66.   4.4 Healthcare, BY End User (USD Billion)
  67.     4.4.1 Point-Of-Care
  68.     4.4.2 Home Diagnostics
  69.     4.4.3 Research Labs
  70.     4.4.4 Security & Biodefense
  71.     4.4.5 Environmental Monitoring
  72.     4.4.6 Food & Beverage Industry
  73.     4.4.7 Others
  74. 5 SECTION V: COMPETITIVE ANALYSIS
  75.   5.1 Competitive Landscape
  76.     5.1.1 Overview
  77.     5.1.2 Competitive Analysis
  78.     5.1.3 Market share Analysis
  79.     5.1.4 Major Growth Strategy in the Healthcare
  80.     5.1.5 Competitive Benchmarking
  81.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  82.     5.1.7 Key developments and growth strategies
  83.       5.1.7.1 New Product Launch/Service Deployment
  84.       5.1.7.2 Merger & Acquisitions
  85.       5.1.7.3 Joint Ventures
  86.     5.1.8 Major Players Financial Matrix
  87.       5.1.8.1 Sales and Operating Income
  88.       5.1.8.2 Major Players R&D Expenditure. 2023
  89.   5.2 Company Profiles
  90.     5.2.1 Abbott Laboratories (US)
  91.       5.2.1.1 Financial Overview
  92.       5.2.1.2 Products Offered
  93.       5.2.1.3 Key Developments
  94.       5.2.1.4 SWOT Analysis
  95.       5.2.1.5 Key Strategies
  96.     5.2.2 Medtronic (US)
  97.       5.2.2.1 Financial Overview
  98.       5.2.2.2 Products Offered
  99.       5.2.2.3 Key Developments
  100.       5.2.2.4 SWOT Analysis
  101.       5.2.2.5 Key Strategies
  102.     5.2.3 Roche Diagnostics (CH)
  103.       5.2.3.1 Financial Overview
  104.       5.2.3.2 Products Offered
  105.       5.2.3.3 Key Developments
  106.       5.2.3.4 SWOT Analysis
  107.       5.2.3.5 Key Strategies
  108.     5.2.4 Siemens Healthineers (DE)
  109.       5.2.4.1 Financial Overview
  110.       5.2.4.2 Products Offered
  111.       5.2.4.3 Key Developments
  112.       5.2.4.4 SWOT Analysis
  113.       5.2.4.5 Key Strategies
  114.     5.2.5 Dexcom (US)
  115.       5.2.5.1 Financial Overview
  116.       5.2.5.2 Products Offered
  117.       5.2.5.3 Key Developments
  118.       5.2.5.4 SWOT Analysis
  119.       5.2.5.5 Key Strategies
  120.     5.2.6 Philips Healthcare (NL)
  121.       5.2.6.1 Financial Overview
  122.       5.2.6.2 Products Offered
  123.       5.2.6.3 Key Developments
  124.       5.2.6.4 SWOT Analysis
  125.       5.2.6.5 Key Strategies
  126.     5.2.7 Biosense Webster (US)
  127.       5.2.7.1 Financial Overview
  128.       5.2.7.2 Products Offered
  129.       5.2.7.3 Key Developments
  130.       5.2.7.4 SWOT Analysis
  131.       5.2.7.5 Key Strategies
  132.     5.2.8 Acon Laboratories (US)
  133.       5.2.8.1 Financial Overview
  134.       5.2.8.2 Products Offered
  135.       5.2.8.3 Key Developments
  136.       5.2.8.4 SWOT Analysis
  137.       5.2.8.5 Key Strategies
  138.     5.2.9 NantHealth (US)
  139.       5.2.9.1 Financial Overview
  140.       5.2.9.2 Products Offered
  141.       5.2.9.3 Key Developments
  142.       5.2.9.4 SWOT Analysis
  143.       5.2.9.5 Key Strategies
  144.   5.3 Appendix
  145.     5.3.1 References
  146.     5.3.2 Related Reports
  147. 6 LIST OF FIGURES
  148.   6.1 MARKET SYNOPSIS
  149.   6.2 US MARKET ANALYSIS BY PRODUCT TYPE
  150.   6.3 US MARKET ANALYSIS BY TECHNOLOGY
  151.   6.4 US MARKET ANALYSIS BY APPLICATION
  152.   6.5 US MARKET ANALYSIS BY END USER
  153.   6.6 KEY BUYING CRITERIA OF HEALTHCARE
  154.   6.7 RESEARCH PROCESS OF MRFR
  155.   6.8 DRO ANALYSIS OF HEALTHCARE
  156.   6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  157.   6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  158.   6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
  159.   6.12 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  160.   6.13 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  161.   6.14 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  162.   6.15 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  163.   6.16 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  164.   6.17 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  165.   6.18 HEALTHCARE, BY END USER, 2024 (% SHARE)
  166.   6.19 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  167.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  168. 7 LIST OF TABLES
  169.   7.1 LIST OF ASSUMPTIONS
  170.     7.1.1
  171.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  172.     7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  173.     7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
  174.     7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
  175.     7.2.4 BY END USER, 2025-2035 (USD Billion)
  176.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  177.     7.3.1
  178.   7.4 ACQUISITION/PARTNERSHIP
  179.     7.4.1

US Healthcare Market Segmentation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Wearable Biosensors
  • Non-wearable Biosensors

Healthcare By Technology (USD Billion, 2025-2035)

  • Electrochemical Biosensors
  • Piezoelectric Biosensors
  • Optical Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Others

Healthcare By Application (USD Billion, 2025-2035)

  • Blood Glucose Testing
  • Cholesterol Testing
  • Blood Gas Analysis
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease Testing
  • Others

Healthcare By End User (USD Billion, 2025-2035)

  • Point-Of-Care
  • Home Diagnostics
  • Research Labs
  • Security & Biodefense
  • Environmental Monitoring
  • Food & Beverage Industry
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓